Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of Protein Biomarkers of Prostate Cancer

This study has been completed.
Information provided by:
University of New Mexico Identifier:
First received: May 5, 2006
Last updated: January 6, 2010
Last verified: November 2009
This study is looking at biomarkers in prostate cancer.

Prostate Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Investigation of Protein Biomarkers of Prostate Cancer

Resource links provided by NLM:

Further study details as provided by University of New Mexico:

Study Start Date: August 2005
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Detailed Description:
  1. To establish primary culture of epithelial cells isolated from prostatectomy samples
  2. To study biomarkers in prostate cancer

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with prostate cancer

Inclusion Criteria:

  • Patients with prostate cancer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00323180

United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Principal Investigator: Marco Bisoffi University of New Mexico
  More Information

Responsible Party: Marco Bisoffi; Principal Investigator, Universtiy of New Mexico Identifier: NCT00323180     History of Changes
Other Study ID Numbers: HRRC 03-376 
Study First Received: May 5, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases processed this record on October 27, 2016